glp-1 iih The Potentially Modifiable Risk Factor in Idiopathic Intracranial Hypertension: Body Weight Impact of GLP-1 receptor agonists

Because injections bypass the digestive system and enter the bloodstream directly, they have a 100% absorption rate

Patients who previously consumed high-fat diets may need to make substantial adjustments, but these modifications typically become easier as new eating patterns are established and weight loss progresses

Current clinical trials and future directions Several clinical trials are expanding the potential uses of GLP-1 drugs

Preclinical PTSD models consistently implicate gut barrier dysfunction, immuneinflammatory activation, HPA axis dysregulation and neurotransmitter imbalance as key mechanistic through-lines (Sherin and Nemeroff, 2011